The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Chitosan in nasal delivery systems for therapeutic drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The blood-brain barrier: Bottleneck in brain drug development
Pardridge, W. M. (2005) · NeuroRX · doi:10.1602/neurorx.2.1.3 · Cited by 2,798
Translocation of inhaled ultrafine particles to the brain
Oberdörster, G., Sharp, Z., Atudorei, V., Elder, A., Gelein, R., Kreyling, W., & Cox, C. (2004) · Inhalation Toxicology · doi:10.1080/08958370490439597 · Cited by 2,606
Chitosan and Its Use as a Pharmaceutical Excipient
Ilium, L. (1998) · Pharmaceutical Research · doi:10.1023/a:1011929016601 · Cited by 1,396
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Self-citationHydrodynamic Radii of Native and Denatured Proteins Measured by Pulse Field Gradient NMR Techniques
Wilkins, D. K., Grimshaw, S. B., Receveur, V., Dobson, C. M., Jones, J. A., & Smith, L. J. (1999) · Biochemistry · doi:10.1021/bi991765q · Cited by 1,010
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Self-citationRecent advances of chitosan nanoparticles as drug carriers
Zeng, Z. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s17296 · Cited by 665
Chitosan as a Novel Nasal Delivery System for Peptide Drugs
Illum, L., Farraj, N. F., & Davis, S. S. (1994) · Pharmaceutical Research · doi:10.1023/a:1018901302450 · Cited by 629
Self-citationChitosan Reduced Gold Nanoparticles as Novel Carriers for Transmucosal Delivery of Insulin
Bhumkar, D. R., Joshi, H. M., Sastry, M., & Pokharkar, V. B. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9257-9 · Cited by 624
Intranasal delivery: Physicochemical and therapeutic aspects
Costantino, H. R., Illum, L., Brandt, G., Johnson, P. H., & Quay, S. C. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.03.025 · Cited by 598
Self-citation
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070
An Overview of Chitosan Nanoparticles and Its Application in Non-Parenteral Drug Delivery
Mohammed, M., Syeda, J., Wasan, K., & Wasan, E. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9040053 · Cited by 1,362
Chitosan as a Wound Dressing Starting Material: Antimicrobial Properties and Mode of Action
Matica, M. A., Aachmann, F. L., Tøndervik, A., Sletta, H., & Ostafe, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235889 · Cited by 818
Chitosan: A Potential Biopolymer in Drug Delivery and Biomedical Applications
Desai, N., Rana, D., Salave, S., Gupta, R., Patel, P., Karunakaran, B., Sharma, A., Giri, J., Benival, D., & Kommineni, N. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041313 · Cited by 628
Current Advances in Chitosan Nanoparticles Based Drug Delivery and Targeting
Garg, U., Chauhan, S., Nagaich, U., & Jain, N. (2019) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2019.023 · Cited by 505
Harugade, A., Sherje, A. P., & Pethe, A. (2023) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2023.105634 · Cited by 474
“The Good, the Bad and the Ugly” of Chitosans
Bellich, B., D’Agostino, I., Semeraro, S., Gamini, A., & Cesàro, A. (2016) · Marine Drugs · doi:10.3390/md14050099 · Cited by 375
Natural product-based nanomedicine: recent advances and issues
Xu, B., Watkins, R., Wu, L., Zhang, C., & Davis, R. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s92162 · Cited by 375
Niosomes: A review on niosomal research in the last decade
Bhardwaj, P., Tripathi, P., Gupta, R., & Pandey, S. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101581 · Cited by 366
Meng, Q., Wang, A., Hua, H., Jiang, Y., Wang, Y., Mu, H., Wu, Z., & Sun, K. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s151474 · Cited by 310
Biodegradable polymers and constructs: A novel approach in drug delivery
Prajapati, S. K., Jain, A., Jain, A., & Jain, S. (2019) · European Polymer Journal · doi:10.1016/j.eurpolymj.2019.08.018 · Cited by 308
Surface-Modified Nanocarriers for Nose-To-Brain Delivery: From Bioadhesion to Targeting
Sonvico, F., Clementino, A. R., Buttini, F., Colombo, G., Pescina, S., Stanisçuaski Guterres, S., Raffin Pohlmann, A., & Nicoli, S. (2018) · doi:10.20944/preprints201802.0077.v1 · Cited by 306
“However, it is worth mentioning that toxicity studies on animal models have evidenced a substantial safety of nanoparticles made of or coated with chitosan [78].”
BackgroundNose-to-brain delivery of BACE1 siRNA loaded in solid lipid nanoparticles for Alzheimer’s therapy
Rassu, G., Soddu, E., Posadino, A. M., Pintus, G., Sarmento, B., Giunchedi, P., & Gavini, E. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.01.031 · Cited by 239
Evidence of nose-to-brain delivery of nanoemulsions: Cargoes but not vehicles
Ahmad, E., Feng, Y., Qi, J., Fan, W., Ma, Y., He, H., Xia, F., Dong, X., Zhao, W., Lu, Y., et al. (2017) · Nanoscale · doi:10.1039/c6nr07581a · Cited by 194
Nanocarriers for targeted drug delivery
Shah, A., Aftab, S., Nisar, J., Ashiq, M. N., & Iftikhar, F. J. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102426 · Cited by 161
Colombo, M., Figueiró, F., de Fraga Dias, A., Teixeira, H. F., Battastini, A. M. O., & Koester, L. S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.055 · Cited by 157
Potential of Chitosan and its derivatives for controlled drug release applications – A review
Safdar, R., Omar, A. A., Arunagiri, A., Regupathi, I., & Thanabalan, M. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2018.10.020 · Cited by 147
Shah, B., Khunt, D., Misra, M., & Padh, H. (2016) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2016.04.076 · Cited by 112
Rassu, G., Porcu, E. P., Fancello, S., Obinu, A., Senes, N., Galleri, G., Migheli, R., Gavini, E., & Giunchedi, P. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics11010008 · Cited by 107
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review
Rassu, G., Soddu, E., Cossu, M., Gavini, E., Giunchedi, P., & Dalpiaz, A. (2016) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.05.002 · Cited by 87
The nasal delivery of nanoencapsulated statins – an approach for brain delivery
Clementino, A., Batger, M., Garrastazu, G., Pozzoli, M., Del Favero, E., Rondelli, V., Gutfilen, B., Barboza, T., Sukkar, M. B., Souza, S. A. L., et al. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s119033 · Cited by 81
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries
Dalpiaz, A., Fogagnolo, M., Ferraro, L., Capuzzo, A., Pavan, B., Rassu, G., Salis, A., Giunchedi, P., & Gavini, E. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.09.013 · Cited by 63
Polymers for the treatment of Alzheimer’s disease
Zhu, Y., Xu, H., Yu, C., Jiang, W., Hou, X., Ma, M., & Wu, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1512941 · Cited by 5
“This is because CS can open the tight junctions between epithelial cells by inhibiting PKC activity and transferring proteins such as ZO-1 therein from the cell membrane into the cytoplasm (Casettari and Illum, 2014; Smith et al., 2005).”
Metadata
- Authors
- Casettari, L., & Illum, L.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2014-09
- Volume
- 190
- Pages
- 189-200
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2071133343
- Cited by
- 444
- References
- 105
- FWCI
- 14.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.